Quantum BioPharma Ltd.
QNTM
$3.89
-$0.16-3.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.59M | 11.99M | 11.67M | 10.95M | 9.20M |
| Depreciation & Amortization | 543.50K | 545.80K | 529.20K | 504.70K | 500.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.87M | 15.30M | 19.17M | 18.67M | 17.28M |
| Operating Income | -14.87M | -15.30M | -19.17M | -18.67M | -17.28M |
| Income Before Tax | -31.97M | -26.96M | -28.71M | -27.98M | -21.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.97 | -26.96 | -28.71 | -27.98 | -21.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 811.80K | 781.70K | 201.10K | 960.70K | 688.00K |
| Net Income | -31.16M | -26.18M | -28.51M | -27.02M | -20.88M |
| EBIT | -14.87M | -15.30M | -19.17M | -18.67M | -17.28M |
| EBITDA | -14.33M | -14.76M | -18.64M | -18.17M | -16.78M |
| EPS Basic | -8.27 | -8.72 | -10.63 | -13.40 | -15.19 |
| Normalized Basic EPS | -5.47 | -5.82 | -6.88 | -8.46 | -9.52 |
| EPS Diluted | -8.27 | -8.72 | -10.63 | -13.40 | -15.19 |
| Normalized Diluted EPS | -5.47 | -5.82 | -6.88 | -8.46 | -9.52 |
| Average Basic Shares Outstanding | 15.14M | 13.13M | 11.28M | 8.40M | 6.02M |
| Average Diluted Shares Outstanding | 15.14M | 13.13M | 11.28M | 8.40M | 6.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |